generic version

Public not to be hit if Natco Pharma licence cancelled: Bayer


September 3rd, 2012 - 11:08 pm ICT by IANS
Chennai, Sep 3 (IANS) The cancellation of a compulsory licence to Hyderabad-based Natco Pharma Ltd to make and sell the generic equivalent of cancer drug Nexavar will not impact public ... Read more...

Posted in Health |

Man claims hair growth pills turned him into woman


July 23rd, 2012 - 7:25 pm ICT by IANS
London, July 23 (IANS) A man who took pills to help cure his baldness has claimed they turned him into a woman, the Daily Mail reported Monday.While William McKee's hair ... Read more...

Posted in Health Science |

US pushing India to hike cancer drug price


July 13th, 2012 - 8:04 pm ICT by IANS
Washington, July 13 (IANS) Even as President Barack Obama is plugging his signature law to lower health care costs at home, his administration is pressurising India and other countries ... Read more...

Posted in Health |

FDA rejects combo cholesterol drug


March 7th, 2012 - 11:04 pm ICT by Aishwarya Bhatt
New York, Mar 7 (THAINDIAN NEWS) Merck & Co Inc has announced that the Food and Drugs Administration has failed to approve its combination cholesterol pill. The company announced that the FDA ... Read more...

Posted in Health |

Ranbaxy approved to make first generic version of Lipitor


December 1st, 2011 - 7:57 pm ICT by IANS
Washington, Dec 1 (IANS) India's largest maker of generic drugs, Ranbaxy Laboratories Ltd has won US approval to sell a generic version of the world's top-selling cholesterol lowering drug Lipitor ... Read more...

Posted in World |

New York Police busts oxycodone drug trafficking ring


March 18th, 2011 - 3:10 pm ICT by ANI
New York, Mar 18 (ANI): With the indictment of 31 members allegedly involved in oxycodone drug trafficking, the New York prosecutors have claimed that a million dollar a year oxycodone-trafficking business that ... Read more...

Posted in World |

Ranbaxy posts $210 mn net profit


May 11th, 2010 - 6:52 pm ICT by IANS
New Delhi, May 11 (IANS) Pharma major Ranbaxy Laboratories Tuesday reported a consolidated net profit of $210 million (Rs.963.1 crore) in the January-March quarter of 2010 against a loss of $153 million ... Read more...

Posted in Business |

Sun Pharma gets US nod for leukaemia drug


November 17th, 2009 - 12:09 pm ICT by IANS
Mumbai, Nov 17 (IANS) Indian drug major Sun Pharmaceuticals Tuesday said it has secured tentative approval from the United States Food and Drugs Administration for the generic version of Gleeven, used to ... Read more...

Posted in Business |

1.25 mn capsules of new swine flu drug enter Indian market


September 25th, 2009 - 8:22 pm ICT by IANS
New Delhi, Sep 25 (IANS) As swine flu cases continue to surge in the country, a pharma company Friday announced that it has pushed 1.25 million capsules of the drug to chemists ... Read more...

Posted in Health |

Decks cleared for Orchid to market anti-infectives in US


September 25th, 2009 - 4:51 pm ICT by IANS
Chennai, Sep 25 (IANS) Decks have been cleared for the city-based Orchid Chemicals and Pharmaceuticals for marketing the generic versions of Zosyn antibiotic, with a US district court rejecting rival Wyeth Laboratories' ... Read more...

Posted in Business |

H1N1 toll 83, anti-flu drug may be allowed in market (Roundup)


August 28th, 2009 - 10:38 pm ICT by IANS
New Delhi, Aug 28 (IANS) With the country reporting five more swine flu deaths Friday, taking the toll from the H1N1 virus to 83, the government is considering selling the anti-influenza drug ... Read more...

Posted in Health |

MJ’s death investigation seeks info on anaesthetic propofol


July 15th, 2009 - 4:45 pm ICT by ANI
London, July 15 (ANI): Officials investigating Michael Jackson's death have sought information from the maker of the powerful anaesthetic propofol as part of their probe.A spokesman for Teva Pharmaceuticals said the ... Read more...

Posted in Entertainment |

Dr Reddy’s net up 89 percent in 2008-09


May 18th, 2009 - 7:01 pm ICT by IANS
Hyderabad, May 18 (IANS) City-based drug major Dr Reddy's Laboratories Monday reported 89 percent jump in net profits to Rs.850 crore ($167 million) in 2008-09 from Rs.450 crore the year before. ... Read more...

Posted in Business |

Ranbaxy posts Rs.1,045 crore net loss in 2008


March 30th, 2009 - 3:41 pm ICT by IANS
Mumbai, March 30 (IANS) Leading drug maker Ranbaxy Laboratories Monday reported a net loss of Rs.1,044.8 crore ($204 million) for 2008 as against a net profit of Rs.617.7 crore in the previous ... Read more...

Posted in Business |

Gilead’s model to enhance availability of anti-AIDS drug


February 22nd, 2009 - 2:50 pm ICT by IANS
New Delhi, Feb 22 (IANS) American bio-pharmaceutical major Gilead, that has entered into generic licensing deals with 10 Indian pharma firms to distribute its HIV drug Viread, is all set to roll ... Read more...

Posted in Uncategorized |

Dr. Reddy’s net rises 10 percent


January 20th, 2009 - 7:18 pm ICT by IANS
Mumbai, Jan 20 (IANS) Leading drug manufacturer, Dr. Reddy's Laboratories, Tuesday announced its net profits were up 10 percent to reach Rs.1.9 billion in the third quarter this fiscal.Overall revenues were up ... Read more...

Posted in Uncategorized |

Sun Pharma gets US nod for women’s drug


September 12th, 2008 - 9:44 pm ICT by IANS
New Delhi, Sep 12 (IANS) Drug manufacturer Sun Pharmaceuticals Friday said it had received final approval from the US Food and Drug Administration to manufacture and sell generic alendronate sodium tablets for ... Read more...

Posted in Uncategorized |

Dabur to supply anti-cancer drug to Thailand


April 9th, 2008 - 7:00 pm ICT by admin
Mumbai April 9 (IANS) Pharmaceutical major Dabur Pharma Ltd Wednesday announced that it has inked a deal with the Government Pharmaceutical Organisation (GPO) of Thailand to supply its key anti-cancer drug to ... Read more...

Posted in Health Science |

Sun Pharma gets US nod for its cancer drug


March 17th, 2008 - 2:40 pm ICT by admin
Mumbai, March 17 (IANS) Gujarat based drug maker Sun Pharmaceutical Industries said Monday it had received a green signal from the US Food and Drug Administration (USFDA) to market the generic version ... Read more...

Posted in Business |

Canada clears Strides Arcolab’s injection


March 12th, 2008 - 7:07 pm ICT by admin
Mumbai, March 12 (IANS) The Canadian health department has given approval to Mumbai-based Strides Arcolab Ltd for its Tazo Pip sterile injection. The company has signed an agreement with a Canadian firm ... Read more...

Posted in Business |

Subscribe